Genomics Articles & Analysis

Genome Prairie announced that they are partnering with the Vancouver-based Fusion Genomics Corporation using Fusion Genomics’ ONETest platform, including FusionCloudTM analytics, to move forward on Genome Prairie’s Genome360 Initiative, as recently announced in Winnipeg on January 8, 2018 by His Honourable Navdeep Bains. “Manitoba is at the heart of a region that is perfectly ...

By Fusion Genomics Corporation

Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced today that its Founder and Chief Executive Officer, Brendan Frey, Ph.D., F.R.S.C., will participate in a panel discussion during the Citi PCA – Private Company Digital Health Conference *VIRTUAL* on May 20, 2021. Details: Session: Artificial Intelligence in Drug Discovery Date and time: Thursday, ...

By Deep Genomics

In the ever-evolving world of genomics, CD Genomics, a leading provider of cutting-edge genomic solutions, has emerged as a pioneer in the field of fungal whole-genome de novo sequencing. Recognizing the crucial importance of understanding the intricate genetic makeup of fungi, the company has developed a comprehensive approach that enables researchers and scientists to delve deep into the ...

By CD Genomics

Epicentre's methyl-seq kit produces whole genome bisulfite sequencing libraries from only 50 ng of genomic DNA. EpiGnome™ follows a unique "post-bisulfite conversion" library construction method which yields highly diverse libraries with uniform coverage Pre-library bisulfite conversion Highly diverse libraries Uniform CpG, CHG, and CHH coverage 1-day procedure Only 50 ng into ...

By Cambio Ltd

CD Genomics, a leading provider of genomic services, is proud to announce a groundbreaking advancement in microsatellite development that is set to transform the landscape of genetic research. Leveraging the power of next-generation sequencing (NGS), CD Genomics enables researchers to harness the full potential of microsatellite markers for a wide range of applications. Microsatellites, also ...

By CD Genomics

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences: Jefferies Healthcare Conference Date: Thursday, June 9 at 9:00 a.m. Eastern Time Guggenheim I&I Spotlight Series – Treg-based Therapies Date: Tuesday, July 12 at 2:45 p.m. Eastern Time Access links for presentations, ...

By Sangamo Therapeutics

"Nutritional genomics is an emerging area of science that is making a significant difference in our approach to enhancing health outcomes by improving our understanding of how to prevent harmful genetic changes that cause developmental defects and degenerative diseases," says Professor Michael Fenech from CSIRO Food and Nutritional Sciences. "In recent years, this research is probably best ...

By CSIRO, the Commonwealth Scientific and Industrial Research Organisation

inDNA Research Labs is an early stage genomics-driven personalized healthcare startup that is at the forefront of trying to bring comprehensive genomic analysis to routine clinical care. Our goal is to democratize the use of genomics technologies by empowering physicians to utilize a patient’s genomic profile to improve clinical decisions thus transforming patient care. This website is ...

By inDNA Research Labs

Uncovering associations between a disease and relevant genomic variants requires both detailed sequence data and detailed clinical data. Join Genuity Science Principal Scientist Anthony Ryan, PhD as he discusses the importance and value of deep phenotyping when looking for genomic associations to disease. In this video he covers: What is meant by ‘deep’ phenotyping. Why ...

By Genuity Science

Presentation entitled “Accelerating drug development through improved gene-disease association using large-scale, real-world datasets” by Robert Lumsden, PhD, Director of Business Development at the 2021 Festival of Genomics & ...

By Genuity Science

Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced the launch of the GRAFTM Population Solution, a set of workflows, services and population-specific graph references to enable large-scale human population studies through more accurate read alignment and variant discovery. Included in today’s release are an updated population-specific NGS analysis ...

By Seven Bridges Genomics

CD Genomics, a trailblazer in genomics and epigenomics research, is proud to announce the launch of MeRIP Sequencing, a cutting-edge technology revolutionizing the analysis of m6A modifications on RNA molecules. This breakthrough method promises to provide researchers with unparalleled insights into the dynamic world of epigenetic modifications, setting a new standard in precision ...

By CD Genomics

The mad scramble to adopt Artificial Intelligence amid the Covid-19 crisis is officially old news. We interact with AI as seamlessly as we do our smartphones, through voice assistants, customer service, automated tasks, self-checkout, fraud detection, in healthcare decisions and infinitely more invisible applications that affect our daily lives. Investments in AI research and ...

By Verge Genomics

SeqOne Genomics, a leader in the field of next generation genomics analysis, announces today a distribution partnership with Global Diagnostic Solutions Ltd (GDS) to commercialize SeqOne’s revolutionary genomics analysis software platform in Middle Eastern markets. Under the terms of this agreement, Global Diagnostic Solutions Ltd. will be responsible for the Business Development, ...

By SeqOne S.A.S.

Company expands AI discovery platform for ‘Programmable’ RNA therapeutics and supports advancement of its portfolio into the clinic Oversubscribed round led by SoftBank Vision Fund 2, with CPP Investments, Fidelity Management & Research Company LLC, Alexandria Venture Investments, Amplitude Ventures, Khosla Ventures, Magnetic Ventures, and True Ventures Deep Genomics, the ...

By Deep Genomics

SeqOne Genomics, provider of next-generation genomic analysis solutions for personalized medicine is proud to announce a new strategic partnership with ILC Instrumentos de Laboratório Científicos to facilitate access to its genomic analysis solutions in Portugal. Through this partnership, ILC Instrumentos de Laboratório Científicos has been appointed as a value added ...

By SeqOne S.A.S.

The executive spoke with BioPharma Dive about the challenges she’s faced winning over investors and building a drug startup. Published Oct. 25, 2022 Gwendolyn Wu https://www.biopharmadive.com/news/alice-zhang-verge-founder-biotechs-CEOs/634836/ ...

By Verge Genomics

A French consortium, coordinated by INRA and gathering CEA (Genoscope), CNRS and the Ecoles Normales Supérieures of Paris and Lyon, sequenced and analyzed the genome of the rainbow trout (Oncorhynchus mykiss), which constitutes the first published genome of a salmonid (salmons and trouts family). This sequence, published on April 22, 2014 in Nature Communications, introduces a new scenario ...

By INRA - French National Institute of Agronomical Research

CD Genomics, a prominent leader in the genomics and transcriptomics arena, proudly unveils its latest innovation, the Degradome Sequencing service. This technology promises to revolutionize the field of transcriptomics research, offering researchers an unprecedented window into RNA degradation patterns and elevating our comprehension of gene regulation and expression. RNA degradation is a ...

By CD Genomics

CD Genomics, a world-leading company in genomic services, today announced that members of its management team would participate in the 37th Society for Immunotherapy of Cancer’s (SITC) Annual Meeting in Boston, MA, November 8-12, 2022. Details for the 37th Annual Meeting & Pre-Conference Programs (SITC 2022) The 37th Annual Meeting & Pre-Conference Programs (SITC 2022) provides a ...

By CD Genomics